According to Medifast's latest financial reports the company's current EPS (TTM) is 10,71 โฌ. In 2022 the company made an earnings per share (EPS) of 11,24 โฌ a decrease over its 2021 EPS that were of 12,30 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | 11,57 โฌ | 2.96% |
2022 | 11,24 โฌ | -8.63% |
2021 | 12,30 โฌ | 60.41% |
2020 | 7,67 โฌ | 32.02% |
2019 | 5,81 โฌ | 42.06% |
2018 | 4,09 โฌ | 100% |
2017 | 2,04 โฌ | 54.3% |
2016 | 1,33 โฌ | -9.04% |
2015 | 1,46 โฌ | 66% |
2014 | 0,88 โฌ | -42.53% |
2013 | 1,53 โฌ | 50% |
2012 | 1,02 โฌ | -12.12% |
2011 | 1,16 โฌ | -5.71% |
2010 | 1,23 โฌ | 66.67% |
2009 | 0,74 โฌ | 127.03% |
2008 | 0,32 โฌ | 23.33% |
2007 | 0,26 โฌ | -18.92% |
2006 | 0,32 โฌ | 68.18% |
2005 | 0,19 โฌ | 37.5% |
2004 | 0,14 โฌ | -36% |
2003 | 0,22 โฌ | -30.56% |
2002 | 0,32 โฌ | 350% |
2001 | 0,07020 โฌ | -57.89% |
2000 | 0,17 โฌ |